he precursor to the Model T." The biggest =hallenge is interpreting the conversation between the body's =rgans and its nervous system, according to Kris Famm, who runs the newly =ormed Bioelectronics R. & D. Unit at GlaxoSmithKline, the world's =eventh-largest pharmaceutical company. "No one has really tr